Human Molecular Genetics Advance Access published online on February 19, 2004
Human Molecular Genetics, doi:10.1093/hmg/ddh090
© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Gastroenterology, Imperial College, Hammersmith Campus, Du Cane Road, London, W12 0NN, United Kingdom
* To whom correspondence should be addressed. E-mail: d.vanheel{at}imperial.ac.uk.
Crohn's disease and ulcerative colitis (the inflammatory bowel diseases) have a strong genetic component. Although over 20 putative susceptibility loci have been identified by individual genome scans, the majority of these loci have not been replicated. Many individual studies are at the lower limit of acceptable power for complex disease linkage analysis. Genome scan meta-analysis (GSMA), by use of sample sizes an order of magnitude greater than individual linkage studies, has increased power to detect novel loci, may confirm or refute regions detected in smaller individual studies, and enables regions to be prioritised for further gene identification efforts. Genome scan data (markers, significance scores) were obtained from ten separate studies and meta-analysis was performed using the GSMA method. These studies comprised 1952 inflammatory bowel disease, 1068 Crohn's disease and 457 ulcerative colitis affected relative pairs. Study results were divided into 34cM chromosomal bins, ranked, weighted by study size, summed across studies and bin-by-bin significance obtained by simulation. A region on chromosome 6p (containing the HLA) met genome wide significance for inflammatory bowel disease. Loci meeting suggestive significance for inflammatory bowel disease were: 2q, 3q, 5q, 7q and 16 (NOD2/CARD15 region); Crohn's disease: 2q, 3q, 6p, 16 (NOD2/CARD15 region), 17q, 19p; and ulcerative colitis: 2q. Clustering of adjacent bins was observed for chromosomes 6p, 16, 19p. The meta-analysis has identified novel loci and prioritised genomic regions for further gene identification studies.
Article
Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs
2 Division of Medical and Molecular Genetics, Guy's King's and St. Thomas' School of Medicine, London, SE1 9RT, UK
3 Whitehead Institute/ MIT Center for Genome Research, Cambridge, MA 02139-1561, USA
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M M Garrity-Park, E V Loftus Jr, W J Sandborn, S C Bryant, and T C Smyrk MHC Class II alleles in ulcerative colitis-associated colorectal cancer Gut, September 1, 2009; 58(9): 1226 - 1233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B L Browning, V Annese, M L Barclay, S A Bingham, S Brand, C Buning, M Castro, S Cucchiara, B Dallapiccola, H Drummond, et al. Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts J. Med. Genet., January 1, 2008; 45(1): 36 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Van Limbergen, E. R. Nimmo, R. K. Russell, H. E. Drummond, L. Smith, N. H. Anderson, G. Davies, I. D. Arnott, D. C. Wilson, and J. Satsangi Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy Hum. Mol. Genet., September 15, 2007; 16(18): 2175 - 2186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Nunez, J Oliver, J L Mendoza, M Gomez-Garcia, A Pinero, C Taxonera, M Diaz-Rubio, M A Lopez-Nevot, E G de la Concha, A Nieto, et al. MYO9B polymorphisms in patients with inflammatory bowel disease Gut, September 1, 2007; 56(9): 1321 - 1322. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Glas, H.-P. Torok, L. Tonenchi, M. Wetzke, V. Beynon, M. Y. Teshome, S. Cotofana, U. Schiemann, T. Griga, W. Klein, et al. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease Int. Immunol., May 1, 2007; 19(5): 621 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Carter, A. Pluzhnikov, A. E. Timms, C. Miceli-Richard, C. Bourgain, B. P. Wordsworth, H. Jean-Pierre, N. J. Cox, L. J. Palmer, M. Breban, et al. Combined analysis of three whole genome linkage scans for Ankylosing Spondylitis Rheumatology, May 1, 2007; 46(5): 763 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Martinez, M. Sanchez-Lopez, J. Varade, A. Mas, M Carmen Martin, V. de las Heras, R. Arroyo, J. Luis Mendoza, M. Diaz-Rubio, B. Fernandez-Gutierrez, et al. Role of the MHC2TA gene in autoimmune diseases Ann Rheum Dis, March 1, 2007; 66(3): 325 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Laukens, H Peeters, B V Cruyssen, T Boonefaes, D Elewaut, F De Keyser, H Mielants, C Cuvelier, E M Veys, K Knecht, et al. Altered gut transcriptome in spondyloarthropathy Ann Rheum Dis, October 1, 2006; 65(10): 1293 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Kendler Reflections on the Relationship Between Psychiatric Genetics and Psychiatric Nosology Am J Psychiatry, July 1, 2006; 163(7): 1138 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Waller, M Tremelling, F Bredin, L Godfrey, J Howson, and M Parkes Evidence for association of OCTN genes and IBD5 with ulcerative colitis Gut, June 1, 2006; 55(6): 809 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. T. Donlin, N. M. Danzl, C. Wanjalla, and K. Alexandropoulos Deficiency in Expression of the Signaling Protein Sin/Efs Leads to T-Lymphocyte Activation and Mucosal Inflammation Mol. Cell. Biol., December 15, 2005; 25(24): 11035 - 11046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Fisher, G. R. Abecasis, B. M. Yashar, S. Zareparsi, A. Swaroop, S. K. Iyengar, B. E.K. Klein, R. Klein, K. E. Lee, J. Majewski, et al. Meta-analysis of genome scans of age-related macular degeneration Hum. Mol. Genet., August 1, 2005; 14(15): 2257 - 2264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P.B. McGovern, P. Hysi, T. Ahmad, D. A. van Heel, M. F. Moffatt, A. Carey, W. O.C. Cookson, and D. P. Jewell Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease Hum. Mol. Genet., May 15, 2005; 14(10): 1245 - 1250. [Abstract] [Full Text] [PDF]
|
|